Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma. Accessed 25 April 2024.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma. Accessed April 25, 2024.
Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma
Chimeric Antigen Receptor (CAR) T‐cell Therapy for People With Relapsed or Refractory Diffuse Large B‐cell Lymphoma [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
ID - 431170
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431170/all/Chimeric_antigen_receptor__CAR__T‐cell_therapy_for_people_with_relapsed_or_refractory_diffuse_large_B‐cell_lymphoma
DB - Evidence Central
DP - Unbound Medicine
ER -